Continuous Blood Glucose Monitoring Market Report by Straits Research

Continuous Blood Glucose Monitoring Market to Achieve USD 14.92 Billion by 2030, Growing at a CAGR of 12.3%

Straits Research has released its latest report on the global continuous blood glucose monitoring market, providing valuable insights into its growth trajectory, market dynamics, and competitive landscape. This press release outlines the key highlights of the report.

Market Overview

The continuous blood glucose monitoring (CBGM) market is poised for significant growth, driven by technological advancements and increasing diabetes prevalence. The market was valued at USD 5.25 billion in 2021 and is projected to reach USD 14.92 billion by 2030, registering a robust compound annual growth rate (CAGR) of 12.3% during the forecast period (2022–2030).

Market Definition

Continuous blood glucose monitoring refers to a real-time monitoring system that tracks blood glucose levels throughout the day and night, enabling better diabetes management. These systems are designed to provide accurate and timely data, enhancing treatment outcomes and improving quality of life for diabetic patients.

Get a Full PDF Sample Copy of the Report @ https://straitsresearch.com/report/continuous-blood-glucose-monitoring-market/request-sample

Market Dynamics

Key Market Trends:

1. Integration of Artificial Intelligence: AI-powered CBGM devices are enabling personalized insights and predictive analytics for improved diabetes management.

2. Rising Adoption of Wearable Devices: Compact and wearable monitoring systems are gaining traction, offering convenience and ease of use for patients.

Market Drivers:

1. Growing prevalence of diabetes globally.

2. Increasing awareness of continuous glucose monitoring benefits over traditional monitoring methods.

Market Opportunities:

1. Expansion of CBGM technologies in emerging economies with rising healthcare expenditures.

2. Development of advanced, cost-effective CBGM solutions catering to diverse patient needs.

Market Segmentation

By Product:

1. Transmitter

2. Receiver

3. Sensor

4. Insulin Pump

By End-User:

1. Hospitals and Clinics

2. Homecare

3. Others

Access Detailed Segmentation @ https://straitsresearch.com/report/continuous-blood-glucose-monitoring-market/segmentation

Regional Insights

• Dominated Region: Asia Pacific continues to dominate the CBGM market, driven by a high diabetes population and increasing adoption of advanced medical technologies.

• Fastest Growing Region: Asia Pacific is also the fastest-growing region, reflecting strong economic growth, improved healthcare infrastructure, and rising awareness of diabetes management.

Key Players

The competitive landscape of the CBGM market is characterized by innovation and strategic collaborations. Key players include:

1. Abbott

2. Dexom Inc.

3. Roche Diagnostics

4. Bayer AG

5. Medtronic Plc.

6. Novo Nordisk

7. Ypsomed AG

8. Senseonics Incorporated

9. Insulet Corporation

For More Information or Query or Customization Before Buying, Visit @ https://straitsresearch.com/buy-now/continuous-blood-glucose-monitoring-market

About Straits Research

Straits Research is committed to delivering high-quality market intelligence that empowers businesses to make informed decisions. Our continuous blood glucose monitoring market report provides in-depth analysis and actionable insights to guide strategic planning and investment.